Skip to main content
Fig. 6 | BMC Gastroenterology

Fig. 6

From: Integration of single-cell and bulk RNA sequencing to establish a prognostic signature based on tumor-associated macrophages in colorectal cancer

Fig. 6

Drug sensitivity and clinical features. (A) The IC50 values of dasatinib, imatinib, gemcitabine and metformin in two risk groups. The relationship between risk score and clinicopathological characteristics: Tumor stage (B), pathologic T (C), pathologic N (D) and pathologic M (E). (Wilcoxon and/or Kruskal-Wallis test). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns no statistical difference

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us